Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus

B Raman, DA Bluemke, TF Lüscher… - European heart …, 2022 - academic.oup.com
Emerging as a new epidemic, long COVID or post-acute sequelae of coronavirus disease
2019 (COVID-19), a condition characterized by the persistence of COVID-19 symptoms …

COVID-19 and cardiovascular disease: from bench to bedside

MK Chung, DA Zidar, MR Bristow, SJ Cameron… - Circulation …, 2021 - Am Heart Assoc
A pandemic of historic impact, coronavirus disease 2019 (COVID-19) has potential
consequences on the cardiovascular health of millions of people who survive infection …

2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute …

Writing Committee, TJ Gluckman, NM Bhave… - Journal of the American …, 2022 - jacc.org
The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review

AH Talasaz, P Sadeghipour, H Kakavand… - Journal of the American …, 2021 - jacc.org
Endothelial injury and microvascular/macrovascular thrombosis are common
pathophysiological features of coronavirus disease-2019 (COVID-19). However, the optimal …

[HTML][HTML] Symptom persistence despite improvement in cardiopulmonary health–insights from longitudinal CMR, CPET and lung function testing post-COVID-19

MP Cassar, EM Tunnicliffe, N Petousi… - …, 2021 - thelancet.com
Background The longitudinal trajectories of cardiopulmonary abnormalities and symptoms
following infection with coronavirus disease (COVID-19) are unclear. We sought to describe …

SARS-CoV-2 infection of human iPSC–derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19

JA Perez-Bermejo, S Kang, SJ Rockwood… - Science translational …, 2021 - science.org
Although coronavirus disease 2019 (COVID-19) causes cardiac dysfunction in up to 25% of
patients, its pathogenesis remains unclear. Exposure of human induced pluripotent stem cell …

Cardiovascular magnetic resonance for patients with COVID-19

SE Petersen, MG Friedrich, T Leiner, MD Elias… - Cardiovascular …, 2022 - jacc.org
COVID-19 is associated with myocardial injury caused by ischemia, inflammation, or
myocarditis. Cardiovascular magnetic resonance (CMR) is the noninvasive reference …

[HTML][HTML] COVID and cardiovascular disease: what we know in 2021

M Chilazi, EY Duffy, A Thakkar, ED Michos - Current atherosclerosis …, 2021 - Springer
Abstract Purpose of Review Coronavirus disease 2019 (COVID-19) has been the cause of
significant global morbidity and mortality. Here, we review the literature to date of the short …

[HTML][HTML] COVID-19 and heart failure: from epidemiology during the pandemic to myocardial injury, myocarditis, and heart failure sequelae

L Italia, D Tomasoni, S Bisegna, E Pancaldi… - Frontiers in …, 2021 - frontiersin.org
A close and intriguing relationship has been suggested between heart failure (HF) and
coronavirus disease 2019 (COVID-19). First, COVID-19 pandemic represented a global …

[HTML][HTML] COVID-19 and the vasculature: current aspects and long-term consequences

B Martinez-Salazar, M Holwerda, C Stuedle… - Frontiers in cell and …, 2022 - frontiersin.org
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first identified in
December 2019 as a novel respiratory pathogen and is the causative agent of Corona Virus …